NO892152D0 - Kondenserte diazepinoner, fremstilling derav og legemidler som inneholder dem. - Google Patents

Kondenserte diazepinoner, fremstilling derav og legemidler som inneholder dem.

Info

Publication number
NO892152D0
NO892152D0 NO892152A NO892152A NO892152D0 NO 892152 D0 NO892152 D0 NO 892152D0 NO 892152 A NO892152 A NO 892152A NO 892152 A NO892152 A NO 892152A NO 892152 D0 NO892152 D0 NO 892152D0
Authority
NO
Norway
Prior art keywords
image
condensed
properties
pinones
diaze
Prior art date
Application number
NO892152A
Other languages
English (en)
Other versions
NO169539B (no
NO892152L (no
NO169539C (no
Inventor
Wolfhard Engel
Wolfgang Eberlein
Gerhard Mihm
Guenter Trummlitz
Norbert Mayer
Adriaan De Jonge
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO892152D0 publication Critical patent/NO892152D0/no
Publication of NO892152L publication Critical patent/NO892152L/no
Publication of NO169539B publication Critical patent/NO169539B/no
Publication of NO169539C publication Critical patent/NO169539C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Thermal Transfer Or Thermal Recording In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO892152A 1988-05-30 1989-05-29 Analogifremgangsmaate til fremstilling av terapeutisk aktive kondenserte diazepinoner NO169539C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3818299A DE3818299A1 (de) 1988-05-30 1988-05-30 Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (4)

Publication Number Publication Date
NO892152D0 true NO892152D0 (no) 1989-05-29
NO892152L NO892152L (no) 1989-12-01
NO169539B NO169539B (no) 1992-03-30
NO169539C NO169539C (no) 1992-07-08

Family

ID=6355412

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892152A NO169539C (no) 1988-05-30 1989-05-29 Analogifremgangsmaate til fremstilling av terapeutisk aktive kondenserte diazepinoner

Country Status (17)

Country Link
US (1) US5006522A (no)
EP (1) EP0344543B1 (no)
JP (1) JPH0228163A (no)
KR (1) KR900018101A (no)
AT (1) ATE78479T1 (no)
AU (1) AU617814B2 (no)
DD (1) DD283822A5 (no)
DE (2) DE3818299A1 (no)
DK (1) DK261289A (no)
FI (1) FI892596A (no)
HU (1) HU203887B (no)
IL (1) IL90418A0 (no)
NO (1) NO169539C (no)
NZ (1) NZ229307A (no)
PT (1) PT90677B (no)
SU (1) SU1731057A3 (no)
ZA (1) ZA894048B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3726908A1 (de) * 1987-08-13 1989-02-23 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE69031845T2 (de) * 1989-04-20 1998-05-07 Boehringer Ingelheim Pharma 6,11-Dihydro-5H-pyrido(2,3-b)(1,5)benzodiazepin-5-one und Thione und ihre Verwendung für die Vorbeugung oder Behandlung von AIDS
DE3919076A1 (de) * 1989-06-10 1990-12-13 Thomae Gmbh Dr K Mittel zur behandlung von erkrankungen des zentralnervensystems und zur foerderung der cerebralen durchblutung
ATE221067T1 (de) * 1993-04-05 2002-08-15 Pharmaceutical Discovery Corp Pyrido(2,3-b)(1,4)benzodiazepinone als m2- rezeptorligand zur behandlung neurologischer störungen
US5561127A (en) * 1994-12-19 1996-10-01 Allelix Biopharmaceuticals, Inc. Muscarinic receptor ligands
JP3521569B2 (ja) * 1995-09-05 2004-04-19 ブラザー工業株式会社 印字制御装置
FR2850654A1 (fr) * 2003-02-03 2004-08-06 Servier Lab Nouveaux derives d'azepines tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP2173355A2 (en) * 2007-07-02 2010-04-14 AC Immune S.A. Pirenzepine and derivatives thereof as anti-amyloid agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3150125A (en) * 1959-09-22 1964-09-22 Wander Ag Dr A 5-(basic substituted)-10, 11-dihydro-11-oxo-5h-dibenzo[b, e][1, 4]diazepine compounds
US3105125A (en) * 1959-10-30 1963-09-24 Bell Telephone Labor Inc Power separation filter
EP0213293B1 (de) * 1985-06-27 1992-01-02 Dr. Karl Thomae GmbH In 11-Stellung substituierte 5,11-Dihydro-6H-pyrido-[2,3-b][1,4]benzodiazepin-6-one, Verfahren zur ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4749788A (en) * 1987-04-13 1988-06-07 A. H. Robins Company, Incorporated Process for the preparation of aryl-pyrido(1,4) benzodiazepines
DE3819444A1 (de) * 1988-06-08 1989-12-14 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3820346A1 (de) * 1988-06-15 1989-12-21 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
PT90677B (pt) 1994-11-30
IL90418A0 (en) 1990-01-18
EP0344543A3 (en) 1990-08-22
US5006522A (en) 1991-04-09
DD283822A5 (de) 1990-10-24
ZA894048B (en) 1991-02-27
FI892596A0 (fi) 1989-05-29
DK261289A (da) 1989-12-01
ATE78479T1 (de) 1992-08-15
NO169539B (no) 1992-03-30
HUT50343A (en) 1990-01-29
KR900018101A (ko) 1990-12-20
DK261289D0 (da) 1989-05-29
NO892152L (no) 1989-12-01
DE58901872D1 (de) 1992-08-27
NZ229307A (en) 1990-11-27
FI892596A (fi) 1989-12-01
SU1731057A3 (ru) 1992-04-30
EP0344543A2 (de) 1989-12-06
NO169539C (no) 1992-07-08
EP0344543B1 (de) 1992-07-22
JPH0228163A (ja) 1990-01-30
HU203887B (en) 1991-10-28
AU617814B2 (en) 1991-12-05
AU3585089A (en) 1989-11-30
DE3818299A1 (de) 1989-12-07
PT90677A (pt) 1989-11-30

Similar Documents

Publication Publication Date Title
EG20273A (en) Process for preparing of pyrazolopyrimidines and their use in the treatment of stress related and other diseases
DK0812190T3 (da) R-enantiomer af N-propargyl-1-aminoindan til behandling af forskellige sygdomme og mesylat, esulat og sulfat deraf
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
ATE168007T1 (de) Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
NO892152D0 (no) Kondenserte diazepinoner, fremstilling derav og legemidler som inneholder dem.
NO172640C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinderivater
NO921447D0 (no) Kondenserte diazepinoner, fremgangsmaate for deres fremstilling, og midler som inneholder disse forbindelser
GR3006606T3 (no)
NO161494C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive benzodiazepiner.
SE8603135L (sv) N-nikotinoylaminosyror
DE69427927D1 (de) Verwendung von Trimetazidin zur Herstellung von Medikamenten für die Behandlung von Gesundheitsstörungen, die durch die Nephrotoxizität von Cyclosporin A bedingt sind.
NO993126D0 (no) Anvendelse av benzoylalkyl-1,2,3,6-tetrahydropyridiner
ATE99933T1 (de) Mittel zur behandlung von nierenbeschwerden.